Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes

医学 肥厚性心肌病 射血分数 心脏病学 内科学 心力衰竭 心房颤动 背景(考古学) 人口 舒张期 心肌病 血压 生物 环境卫生 古生物学
作者
Beatrice Musumeci,Giacomo Tini,Elena Biagini,Marco Merlo,Chiara Calore,Enrico Ammirati,Mattia Zampieri,Domitilla Russo,Giulia Grilli,Caterina Santolamazza,Riccardo Vio,Marta Rubino,Raffaello Ditaranto,Annamaria Del Franco,Paola Sormani,Vanda Parisi,Emanuele Monda,Pietro Francia,Alberto Cipriani,Giuseppe Limongelli
出处
期刊:International Journal of Cardiology [Elsevier BV]
卷期号:400: 131784-131784 被引量:15
标识
DOI:10.1016/j.ijcard.2024.131784
摘要

Background A minority of patients with hypertrophic cardiomyopathy (HCM) presents advanced heart failure (HF) during their clinical course, in the context of left ventricular (LV) remodeling with reduced LV ejection fraction (LVEF), or of severe diastolic dysfunction without impaired LVEF. Aim of this study was to describe a multicentric end stage (ES) HCM population and analyze clinical course and outcome among its different phenotypes. Methods Data of all HCM patients from 7 Italian referral centres were retrospectively evaluated. ES was diagnosed in presence of: LVEF <50% (ES-rEF) or NYHA functional class ≥II with severe diastolic dysfunction (ES-pEF). Outcomes were: HCM-related and all-cause mortality; combined arrhythmic events; advanced HF treatments. Results Study population included 331 ES patients; 87% presented ES-rEF and 13% ES-pEF. At ES recognition, patients with ES-pEF were more commonly females, had more frequently NYHA III/IV, atrial fibrillation and greater maximal LV wall thickness. Over a median follow-up of 5.6 years, 83 (25%) patients died, 46 (15%) experienced arrhythmic events and (26%) 85 received advanced HF treatments. Incidence of HCM-related and all-cause mortality, and of combined arrhythmic events did not differ in ES-pEF and ES-rEF patients, but ES-pEF patients were less likely to receive advanced HF treatments. Older age at ES recognition was an independent predictor of increased HCM-related mortality (p = 0.01) and reduced access to advanced HF treatments (p < 0.0001). Conclusions Two different HCM-ES phenotypes can be recognized, with ES-pEF showing distinctive features at ES recognition and receiving less frequently advanced HF treatments. Older age at ES recognition has a major impact on outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
科研通AI6.2的应助被zzZ5采纳,获得30
刚刚
高贵路灯完成签到,获得积分10
刚刚
番茄完成签到,获得积分10
刚刚
思源的应助被luluyang采纳,获得10
刚刚
刚刚
林佳明完成签到,获得积分10
刚刚
1秒前
欢喜的迎丝完成签到,获得积分10
1秒前
龙1完成签到,获得积分10
1秒前
lijunliang完成签到,获得积分10
1秒前
2秒前
2秒前
rrfhl完成签到,获得积分10
2秒前
cc完成签到,获得积分10
2秒前
在水一方的应助被wepoch采纳,获得10
2秒前
3秒前
Dunphy完成签到 ,获得积分10
3秒前
搜集达人的应助被六六采纳,获得10
3秒前
吃葡萄不吐葡萄皮的应助被zcd采纳,获得80
4秒前
Peiqi的应助被NattyPoe采纳,获得30
4秒前
4秒前
鲸落发布了新的文献求助20
5秒前
Lyuhng+1发布了新的文献求助10
5秒前
5秒前
没烦恼有头脑完成签到 ,获得积分10
5秒前
killGc完成签到,获得积分10
5秒前
Hoshino完成签到,获得积分20
5秒前
科目三的应助被玉意采纳,获得10
5秒前
61发布了新的文献求助10
5秒前
迅速的晟睿完成签到,获得积分20
5秒前
白马非马完成签到,获得积分10
5秒前
我无语完成签到 ,获得积分10
6秒前
6秒前
paddi完成签到,获得积分10
6秒前
6秒前
海伦发布了新的文献求助10
6秒前
Rainor发布了新的文献求助10
6秒前
不吃西瓜完成签到,获得积分10
6秒前
ss完成签到,获得积分20
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180617
求助须知:如何正确求助?哪些是违规求助? 9570702
关于积分的说明 21813868
捐赠科研通 7776860
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557571
邀请新用户注册赠送积分活动 2479253